Recall of Specific Types of Breast Implants and Tissue Expanders Has Far-Reaching Impact on Patients With Breast Cancer
In Japan, insurance coverage for breast implantation is limited to procedures using Allergen-manufactured products.
Lymphoma
Follicular Lymphoma: Interactions With Surrounding Cells to Identify Therapeutic Targets
Characterizing gene expression profiles of FL cells from intrafollicular and extrafollicular regions may help to identify future therapeutic targets.
Hepatosplenic T-cell Lymphoma: Recent Progress and Future Considerations
Researchers reviewed the clinical/pathologic aspects of HSTCL and summarized the latest molecular studies and potential novel therapeutic targets.
COVID-19, SARS-CoV-2 Infection Phenotypes Vary With Different Tumor Subtypes
Among patients with cancer, tumor subtypes may influence varying susceptibility to SARS-CoV-2 and COVID-19 disease phenotypes.
Radiotherapy Response Time Did Not Dictate Outcomes for Gastrointestinal Low-Grade B-Cell Lymphoma
Delayed evaluation could decrease unnecessary invasive tests.
Waldenström Macroglobulinemia Treated With Ixazomib Combination Therapy: Long-Term Follow Up
Investigators measured ixazomib, dexamethasone, and rituximab combination treatment among patients with treatment-naive Waldenström macroglobulinemia.
2021 Update on Diagnosis, Risk Stratification, and Management of Cutaneous B-Cell Lymphomas
Researchers assessed diagnosis, risk-stratification, and management of 3 distinct subgroups of primary cutaneous lymphomas.
Low-Dose Anti-PD1 Therapies in Relapsed/Refractory Classical Hodgkin Lymphoma
A small study suggests that low-dose pembrolizumab or nivolumab may be effective and safe for the treatment of r/r classical Hodgkin lymphoma.
Managing Skin Flare Reactions in Patients Receiving Mogamulizumab for Cutaneous T-cell Lymphoma
Using a grading system for skin flare reactions increases potential for continuing administration of mogamulizumab despite the occurrence of this adverse effect.
Lipid Microenvironment With B-Cell Lymphoma and Natural Killer Cell Function
Lipid changes in the B-cell lymphoma microenvironment may influence natural killer cell metabolism and function.
-
Loading...
-
Loading...
Next post in Lymphoma
